Veeva Systems (NYSE:VEEV – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 6.220-6.220 for the period, compared to the consensus earnings per share estimate of 6.160. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. Veeva Systems also updated its FY25 guidance to $6.22 EPS.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on VEEV. Canaccord Genuity Group decreased their price objective on Veeva Systems from $220.00 to $210.00 and set a hold rating for the company in a report on Friday, May 31st. Guggenheim boosted their price target on Veeva Systems from $211.00 to $233.00 and gave the stock a buy rating in a research report on Thursday, July 18th. BTIG Research began coverage on Veeva Systems in a research note on Tuesday, July 9th. They set a buy rating and a $240.00 price objective on the stock. Bank of America decreased their target price on shares of Veeva Systems from $240.00 to $204.00 and set a neutral rating for the company in a research note on Friday, May 31st. Finally, Evercore ISI lowered their target price on shares of Veeva Systems from $230.00 to $200.00 and set an in-line rating on the stock in a report on Friday, May 31st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Veeva Systems currently has a consensus rating of Moderate Buy and a consensus target price of $230.41.
Check Out Our Latest Analysis on VEEV
Veeva Systems Stock Performance
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its quarterly earnings data on Thursday, May 30th. The technology company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.10. Veeva Systems had a return on equity of 12.74% and a net margin of 22.34%. The firm had revenue of $650.35 million for the quarter, compared to analysts’ expectations of $641.73 million. Research analysts predict that Veeva Systems will post 4.19 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, SVP Jonathan Faddis sold 2,353 shares of Veeva Systems stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total value of $470,600.00. Following the completion of the sale, the senior vice president now directly owns 9,035 shares in the company, valued at $1,807,000. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Veeva Systems news, CFO Timothy S. Cabral sold 15,000 shares of the stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $184.33, for a total transaction of $2,764,950.00. Following the sale, the chief financial officer now directly owns 8,391 shares in the company, valued at $1,546,713.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Jonathan Faddis sold 2,353 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total transaction of $470,600.00. Following the completion of the transaction, the senior vice president now directly owns 9,035 shares in the company, valued at $1,807,000. The disclosure for this sale can be found here. Corporate insiders own 10.50% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Read More
- Five stocks we like better than Veeva Systems
- Low PE Growth Stocks: Unlocking Investment Opportunities
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- Insider Buying Explained: What Investors Need to Know
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.